• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,171.29 -96.05
( -0.13%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
67,130.34 800.84
(1.21%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Colinz Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
531210
INE923C01011
69.7038625
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.76
7.07
EPS(TTM)
Face Value()
Div & Yield %
4.08
10
0
 

haryana capfin ltd
Vinny Overseas standalone net profit declines 58.42% in the March 2026 quarter
May 21,2026
Net profit of Vinny Overseas declined 58.42% to Rs 0.42 crore in the quarter ended March 2026 as against Rs 1.01 crore during the previous quarter ended March 2025. Sales rose 14.97% to Rs 37.10 crore in the quarter ended March 2026 as against Rs 32.27 crore during the previous quarter ended March 2025.

For the full year,net profit declined 82.14% to Rs 0.92 crore in the year ended March 2026 as against Rs 5.15 crore during the previous year ended March 2025. Sales rose 2.51% to Rs 124.62 crore in the year ended March 2026 as against Rs 121.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales37.1032.27 15 124.62121.57 3
OPM %4.071.64 -4.324.94 -
PBDT1.942.23 -13 7.3612.24 -40
PBT0.360.98 -63 1.367.19 -81
NP0.421.01 -58 0.925.15 -82